Lifevantage Corporation
$ 6.86
5.86%
03 Dec - close price
- Market Cap 87,130,000 USD
- Current Price $ 6.86
- High / Low $ 6.94 / 6.49
- Stock P/E 8.27
- Book Value 2.61
- EPS 0.83
- Next Earning Report 2026-02-03
- Dividend Per Share $0.17
- Dividend Yield 2.62 %
- Next Dividend Date 2025-12-15
- ROA 0.12 %
- ROE 0.33 %
- 52 Week High 26.94
- 52 Week Low 5.94
About
LifeVantage Corporation, based in Sandy, Utah, is a leader in the nutrigenomics sector, dedicated to enhancing health through a range of scientifically formulated products. The company's portfolio features dietary supplements, nootropics, prebiotics, probiotics, and advanced skin and hair care solutions, all aimed at promoting healthier aging and improving overall quality of life. With a strong emphasis on research and development, LifeVantage is well-positioned to capitalize on the growing consumer interest in preventive health solutions, indicating significant opportunities for growth within the expanding wellness industry.
Analyst Target Price
$14.50
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-27 | 2025-09-04 | 2025-05-06 | 2025-02-05 | 2024-10-29 | 2024-08-28 | 2024-05-02 | 2024-01-30 | 2023-11-09 | 2023-08-28 | 2023-05-04 | 2023-02-02 |
| Reported EPS | 0.18 | 0.17 | 0.26 | 0.22 | 0.15 | 0.14 | 0.21 | 0.1 | 0.13 | 0.17 | 0.08 | -0.07 |
| Estimated EPS | 0.21 | 0.2 | 0.14 | 0.13 | 0.15 | 0.21 | 0.16 | 0.04 | 0.15 | 0.2 | 0.15 | 0.05 |
| Surprise | -0.03 | -0.03 | 0.12 | 0.09 | 0 | -0.07 | 0.05 | 0.06 | -0.02 | -0.03 | -0.07 | -0.12 |
| Surprise Percentage | -14.2857% | -15% | 85.7143% | 69.2308% | 0% | -33.3333% | 31.25% | 150% | -13.3333% | -15% | -46.6667% | -240% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-03 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.1533 |
| Currency | USD |
Previous Dividend Records
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2025-12-15 | 2025-09-16 | 2025-06-13 | 2025-03-17 | 2024-12-16 | 2024-09-17 | 2024-06-14 | 2024-03-15 | 2023-12-15 | 2023-09-22 |
| Amount | $0.045 | $0.045 | $0.045 | $0.04 | $0.04 | $0.04 | $0.04 | $0.035 | $0.035 | $0.4 |
Next Dividend Records
| Dividend per share (year): | $0.17 |
| Dividend Yield | 2.62% |
| Next Dividend Date | 2025-12-15 |
| Ex-Dividend Date | 2025-12-01 |
Recent News: LFVN
2025-11-02 10:40:39
This article provides a detailed overview of Lifevantage Corporation (LFVN) stock performance, key financial statistics, and analyst insights. It covers current stock price movements, historical data, upcoming earnings, and employee information, alongside dividend details and various financial ratios. The piece also includes trading ideas and frequently asked questions about LFVN.
2025-10-13 20:15:00
LifeVantage Corporation CEO Steve Fife will present at the LD Micro Main Event XIX in San Diego on October 20, 2025, to engage with investors. The health and wellness company, specializing in nutrigenomics, will offer a live webcast of the presentation on its Investor Relations website. The article also provides insights into potential positives and negatives, along with detailed insider trading and hedge fund activity for LFVN.
2025-10-13 20:05:10
LifeVantage Corporation will participate in the LD Micro Main Event XIX on October 20, 2025, where President and CEO Steve Fife will present to investors. The presentation will be accessible via webcast on the company's Investor Relations website. LifeVantage, a health and wellness company focused on nutrigenomics, will discuss its products and business opportunities.
2025-10-13 20:05:00
LifeVantage Corporation announced its CEO, Steve Fife, will participate in the LD Micro Main Event XIX on October 20, 2025, in San Diego, CA. Fife will meet with investors and present the company's information. LifeVantage, a nutrigenomics company, develops products aimed at activating optimal cellular health.
2025-02-25 18:03:16
Retail investors hold the largest stake in LifeVantage Corporation (NASDAQ:LFVN) with 41% ownership, giving them significant influence over company decisions. Institutions own 27% of the company, while hedge funds account for 12%, with Renaissance Technologies LLC being the largest single shareholder at 6.2%. Insiders also maintain a notable presence, holding shares valued at US$40 million.
2025-01-14 00:00:00
LifeVantage Corporation has released results from a third-party cell study showing the synergistic effects of its "Healthy Weight Stack," comprising Protandim Nrf2 Synergizer and MindBody GLP-1 System. The study indicates that the combined supplements amplify benefits, activate 22 genes targeting age-related organ decline, and enhance antioxidant defense as well as fat metabolism. These findings mark a significant advancement in gene-activated approaches to weight management and healthy aging.
